MTD vs STRO
Mettler-Toledo International Inc (MTD) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MTD currently screens at market cap $23.20B and trailing P/E 26.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MTD and STRO stock pages for the full models.
Not investment advice.